Dr Madhuri Patil, president-elect of the Indian Society for Assisted Reproduction and one of the clinicians involved, said the inclusion of “metabolic” in the new name is especially relevant given India’s high rates of metabolic syndrome and insulin resistance. #PMOS #pcosnamechange #pcos

“With the advances in understanding this condition, the new name is more comprehensive.” says Anuja Dokras, MD, PhD, a professor of women’s health and director of the Penn PCOS Center at the Perelman School of Medicine in Philadelphia. Read the full article: www.everydayhealth.com/pcos/myths-d...

Lorna Berry, a patient with #PMOS who worked on the initiative, said last year that she hoped the change would lead to "better outcomes for women with #PCOS across their lifetime". Read the full article on @sciencealert.com.web.brid.gy: www.sciencealert.com/pcos-is-offi... #pcosnamechange

📣 #pcosnamechange Polyendocrine Metabolic Ovarian Syndrome #PMOS is the new name for the condition previously known as Polycystic Ovary Syndrome #PCOS, which impacts 1 in 8, or more than 170 million women worldwide. 📄 Resources in multiple languages are available: www.mchri.org.au/guidelines-r...

www.youtube.com/watch?v=aPea... #PCOSnamechange #PMOS Polyendocrine Metabolic Ovarian Syndrome

PCOS has a new name - Polyendocrine Metabolic Ovarian Syndrome (PMOS). An accurate name for a condition affecting 170 million women globally. Patients & professionals working together from the start. More information at: bit.ly/3R0pIYw #PCOSNameChange #PMOS #PCOS

Finally, polycystic ovary syndrome #PCOS has a new name: polyendocrine metabolic ovarian syndrome #PMOS 👉 better reflecting the complex hormonal and metabolic nature of this condition affecting 170 million women worldwide. Read more here: www.thelancet.com/journals/lan...

Delighted to have been part of this international consensus on the renaming of #PCOS, a lifelong metabolic disorder affecting 15% of women, to Polyendocrine Metabolic Ovarian Syndrome #PMOS share.google/EkubYi5BLx83...

Polyendocrine metabolic ovarian syndrome (PMOS) ‘Unprecedented’ global effort gives new name to polycystic ovary syndrome – and new hope to millions of women www.theguardian.com/society/ng-i... @veritypcos.bsky.social Prof @helenateede.bsky.social

📣 The name of PCOS is changing. 🤝 The new name was decided after survey answers from 22,000 individuals including patients, their family members, and health professionals. 56 organizations (societies, patient organizations) were involved. The name will be revealed May 12 at #ECE2026 in Prague 🇨🇿

📄 SESSION 4 Tanja Turunen Melanie Cree 🎤 Lina Schiffer MRC Laboratory of Medical Sciences, London 🇬🇧 "Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women"

📄 SESSION 4 Tanja Turunen Melanie Cree 🎤 Manuel Tena-Sempere University of Córdoba 🇪🇸 "Targeting cannabinoids and incretins in the treatment of PCOS"

📄 SESSION 3 Co-Chairs:
Nathalie di Clemente @sandrograca.bsky.social 🎤 Farheen Shaikh Zydus Therapeutics Inc 🇺🇸 “Saroglitazar / PPAR gamma agonist in PCOS treatment”

⚡ RAPID-FIRE TALKS (Session 2) 🎤 Christophe Richer dit Laflèche Université de Sherbrooke 🇨🇦 🎤 Martina Curcio University of Udine 🇮🇹 🎤 Tamara Baltic 🇬🇷 🎤 Saad Amer Nuffield Health Derby Hospital 🇬🇧 🎤 Jacob Short Karolinska Institutet 🇸🇪

SESSION 2, co-chaired by:
Damian Romero Lulia-Alexandra Pirga 🎤 Dorte Glintborg University of Southern Denmark 🇩🇰 "Increased prospective cardiovascular disease risk in 127,517 Nordic women with polycystic ovary syndrome. A national cohort study."

📄 SESSION 2, co-chaired by:
Damian Romero Lulia-Alexandra Pirga 🎤 Irem Sonmezoglu Kutuk Hacettepe University School of Medicine 🇹🇷 "Reduced circulating and skeletal muscle MOTS-c expression in women with polycystic ovary syndrome: Evidence for disrupted mitochondrial-derived peptide regulation”

📄 SESSION 2 Co-Chairs:
Damian Romero Lulia-Alexandra Pirga 🎤 Mojca Jensterle University of Ljubljana 🇸🇮 “GLP-1 and GLP-1/GIP receptor agonists in PCOS treatment”

📋 SESSION 1, co-chaired by: Prof. Dr. Mojca Jensterle Sever
Anja Dekanski 🎤 Damian Romero Mississippi Medical Center 🇺🇸 "Targeting the Androgen Receptor to Treat Cardiometabolic Complications in PCOS"

📄 SESSION 1, co-chaired by: Prof. Dr. Mojca Jensterle Sever
Anja Dekanski 🎤 Prof @helenateede.bsky.social Monash University 🇦🇺 "Limited utility of cluster analysis in polycystic ovary syndrome for defining clinically meaningful subtypes and case–control discrimination in unselected populations"

📋 SESSION 1 Prof. Dr. Mojca Jensterle Sever
Anja Dekanski 🎤 Tanja Turunen @ki.se 🇸🇪 "Cell type-specific endometrial dysfunctions across the menstrual cycle in polycystic ovary syndrome"

SESSION 1 Co-chaired by Prof. Dr. Mojca Jensterle Sever & Anja Dekanski 🎤 Nathalie di Clemente Inserm, Sorbonne Université 🇫🇷 "A blocking antibody against anti-Müllerian hormone restores ovulation and normal androgen levels in a spontaneous rat model of polycystic ovary syndrome"

…and we’re off!! AEPCOS UPDATE MEETING #ECE2026 Novel therapies for the treatment of PCOS Prague 🇨🇿

⏳ You can still register to join us in Prague 🇨🇿 for our 2026 Update Meeting 🤩 🔗 ae-society.org/meetings/ "Novel therapies for the treatment of PCOS" Prague Congress Centre, 9th of May, 2026 #ECE2026

"Novel therapies for the treatment of PCOS" ✨ AE-PCOS Update Meeting 🗓️ Sat, 9 May, 2026 🇨🇿 Prague, Czech Republic 📍 #ece2026 European Society of Endocrinology (ESE) @esendocrinology.bsky.social 📄 Program: ae-society.org/meetings/ 🤩 Looking forward to seeing everyone in Prague! Safe travels.

Thank you all for joining today's Meet The Professor session with Prof Michael O'Reilly. Looking forward to seeing you at the Update Meeting in Prague in a few weeks! 🔗 ae-society.org

Looking forward to seeing all AE-PCOS EC-SIG members at our upcoming Meet the Professor session 👉 with Prof. Michael O'Reilly, Consultant Endocrinologist; Principal Investigator; HRB Emerging Clinician Scientist, Royal College of Surgeons in Ireland (RCSI). 🗓️ April 23, 2026 ⏰ 10:30am – 11:30am EDT

High social deprivation is associated w/ increased risk of new onset metabolic syndrome & may contribute to the higher risk in Black compared to White women w/ PCOS doi.org/10.1210/jend... Highlights importance of considering social determinants of health, partic. in an already high-risk population

🚨 Early-bird registration ends soon! AE-PCOS 2026 Update Meeting Topic: “New therapeutic approaches in #PCOS” 📍 Prague Congress Centre 🇨🇿 #ECE2026 @esendocrinology.bsky.social 🗓️ May 9, 2026 Register now and read the preliminary program on our website: ae-society.org/meetings/

Looking forward to seeing you all at our 2026 Update Meeting: “New therapeutic approaches in #PCOS”, taking place in Prague 🇨🇿 #ECE2026 @esendocrinology.bsky.social 🗓️ May 9, 2026 Registration and program: ae-society.org/meetings/ Pay attention to the deadlines approaching!

We are excited to invite all AE-PCOS EC-SIG members to our next MTP session - with Prof. Michael O'Reilly. 🗓️ April 23, 2026 ⏰ 10:30am – 11:30am EDT (Zoom link sent to EC-SIG members, please check your email) 👉 Hear about Prof. O'Reilly's career; 👉 Ask your questions directly; 👉 Network with peers.

✍️ Registration OPEN for the 2026 update meeting “New therapeutic approaches in PCOS” - which will take place in Prague, Czech Republic 🇨🇿 🗓️ May 9, 2026 👉 ae-society.org/meetings #ece2026 @esendocrinology.bsky.social Preliminary program available on our website 📄

We will have two presenters at our EC-SIG meeting: 🎤 Isha Safdar 📄 Feasibility of Continuous Glucose Monitor Use and Glucose Pattern Analysis in Females with PCOS 🎤 Caitlin MacRae 📄 Androgens in the PCOS brain - transgenic and viral approaches to investigate androgen-sensitive neuronal connectivity

⏰ Reminder 👉 Abstract submission deadline approaching! ⏳ Tue, 20 Jan 2026, 5:59pm EST ae-society.org/meetings/ AE-PCOS UPDATE MEETING at #ECE2026 @esendocrinology.bsky.social "New therapeutic approaches in PCOS" 📍 Prague, Czech Republic 🇨🇿 🗓️ May 9, 2026

Join members of the Society’s Science Committee for a virtual, round-table discussion on the essentials of Patient and Public Involvement and Engagement (PPIE) for discovery scientists next Friday 23 Jan 12:30-13:30. Find out more: bit.ly/3LlXTYe

Dear AE-PCOS friend or member, Happy New Year! 🎉✨ 📣 YCYMI 👉 Check your email for the latest #AEPCOS newsletter, with highlights of the 23rd AE-PCOS Annual Meeting in San Antonio, Texas, plus updates from president Prof Terhi Piltonen, Early Career SIG events and news, and much more...

Thanks to you all, 2025 was fabulous 🤩🎉 Let's make 2026 even more impressive 💪✨ ae-society.org/meetings Our 2026 Update meeting “New therapeutic approaches in PCOS” will take place in Prague, Czech Republic 🇨🇿 on May 9, 2026 👉 ABSTRACT SUBMISSION IS OPEN! ⏳ Deadline: Tuesday 20 Jan 2026, 5:59pm EST

Season’s Greetings to all our AE-PCOS members, followers, and friends/family! 💖 Wishing you comfort, joy, and good health this holiday season. 🎄 We are deeply grateful for your support and wish you peace and wellness in the year ahead. 💫

Are you a postdoc or student working on a neuroendocrine research project?🧠🔬 💸Get up to £8,000 support for consumables/other research costs to enable you to carry out the best possible neuroendocrine research project. Deadline 30.1.26 More & apply: neuroendo.org.uk/grants

Plan your trip for #ECE2026 now, with recommendations on our website 👉 ow.ly/qBpT50XBMKT Travel sustainably by direct trains from Austria, Germany or Poland, or you can fly to Prague. Local public transport is included in your registration fee (until 21 April 2026).

Large retrospective cohort study shows that exposure to GLP-1 RAs before pregnancy results in higher weight gain & more pregnancy complications than no GLP-1 RAs exposure prior to pregnancy - GLP-1 RAs will not be a good solution for women with PCOS desiring fertility jamanetwork.com/journals/jam...

🗓️ Meet the Professor session - TODAY, Thu, Nov. 27th at 7am EST (1pm CET). 🎙️ Learn more about Dr Paolo Giacobini's work and insights on neuroendocrinology. 🔗 EC-SIG members, check your email for the Zoom link 👍

May 9th, 2026 📍 Prague 🇨🇿 #ECE2026 🔗 www.ese-hormones.org/ece2026 “Novel therapies for the treatment of PCOS” Sessions will highlight advances in targeted pharmacological treatments, lifestyle and metabolic interventions, and novel approaches involving neuroendocrine, immune, and gut–brain pathways.

🗓️ Meet the Professor session - Thursday, Nov. 27 @ 7am EST (1pm CET). 🎤 Learn more about Dr Paolo Giacobini's work and insights on neuroendocrinology. 🔗 EC-SIG members, check your email for the Zoom link 👍

💵 Spending on AI-powered wearables is expected to exceed $300 billion in 2033. ❤️ Healthcare use cases are leading adoption. ⌚️ Wearables transform the way people approach health and wellness. tech.yahoo.com/wearables/ar...

ORAL PRESENTATIONS Chairs: Rebecca Campbell & Mahua Ghosh Development of an artificial intelligence foundation model for the interpretation of pelvic ultrasonography in PCOS 👉 Eeshan Rehaani 🇺🇸

ORAL PRESENTATIONS Chairs: Rebecca Campbell & Mahua Ghosh Predictors of disordered eating in women with PCOS: a meta-analysis 👉 Riley Huddleston 🇺🇸

ORAL PRESENTATIONS Chairs: Rebecca Campbell & Mahua Ghosh Health-related quality of function in PCOS: assessing the impact of combined oral contraceptive pills and metformin therapy 👉 Joshua Ewy 🇺🇸

SESSION 7: PCOS and Reproduction Chairs: Marcelle Cedars & Richard Legro Long-Term Effects of Prenatal Metformin Exposure and Maternal PCOS on Childhood Immunity and Mental Health 🎤 Prof Eszter Vanky 🇳🇴

SESSION 7: PCOS and Reproduction Chairs: Richard Legro & Marcelle Cedars Myo-inositol Supplementation to Prevent Pregnancy Complications in Women with #PCOS - The MYPP trial 🎤 by Prof Joop Laven 🇳🇱

Early-career networking session (chaired by Dr Tina Gorsek & Dr Jamie Benham) 23rd Annual Meeting of the AEPCOS Society in San Antonio, TX 🇺🇸